NASDAQ:SNES - SenesTech Stock Price, Forecast & News

$0.56

-0.01 (-1.75 %)

(As of 01/21/2020 12:32 PM ET)

Add

Compare

Today's Range

$0.55

Now: $0.56▼

$0.56

50-Day Range

$0.50

MA: $0.56▼

$0.60

52-Week Range

$0.46

Now: $0.56▼

$1.95

Volume400 shs

Average Volume161,651 shs

Market Capitalization$15.84 million

P/E RatioN/A

Dividend YieldN/A

Beta1.68

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. The company focuses on commercializing ContraPest, a fertility control product for use in controlling rat populations. It is also developing a pipeline of fertility control and animal health products, including feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment. Read More…

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Agricultural chemicals

Sub-IndustryN/A

SectorMedical

Current SymbolNASDAQ:SNES

Previous Symbol

CUSIPN/A

CIK1680378

Webhttp://www.senestech.com/

Phone928-779-4143

Debt

Debt-to-Equity Ratio0.04

Current Ratio4.73

Quick Ratio3.66

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$300,000.00

Price / Sales52.81

Cash FlowN/A

Price / Cash FlowN/A

Book Value$0.27 per share

Price / Book2.07

Profitability

EPS (Most Recent Fiscal Year)($0.63)

Net Income$-11,910,000.00

Net Margins-4,568.52%

Return on Equity-200.80%

Return on Assets-154.63%

Miscellaneous

Employees40

Outstanding Shares28,290,000

Market Cap$15.84 million

Next Earnings Date3/26/2020 (Estimated)

OptionableNot Optionable

Receive SNES News and Ratings via Email

Sign-up to receive the latest news and ratings for SNES and its competitors with MarketBeat's FREE daily newsletter.

(Ad)

If you're looking to potentially make 1,000% in gains, then you NEED this biotech stock. This company discovered a medical breakthrough that may end heart attacks FOREVER! Estimated annual sales are $60 billion. The FDA has all but said it's going to approve the drug. Once that happens, the stock price could double overnight. But you must be onboard BEFORE FDA approval.

SenesTech (NASDAQ:SNES) Frequently Asked Questions

What is SenesTech's stock symbol?

SenesTech trades on the NASDAQ under the ticker symbol "SNES."

How were SenesTech's earnings last quarter?

SenesTech Inc (NASDAQ:SNES) announced its quarterly earnings results on Tuesday, November, 12th. The company reported ($0.09) earnings per share for the quarter. The business earned $0.04 million during the quarter, compared to analysts' expectations of $0.04 million. SenesTech had a negative net margin of 4,568.52% and a negative return on equity of 200.80%. View SenesTech's Earnings History.

When is SenesTech's next earnings date?

SenesTech is scheduled to release their next quarterly earnings announcement on Thursday, March 26th 2020. View Earnings Estimates for SenesTech.

Has SenesTech been receiving favorable news coverage?

Media headlines about SNES stock have trended neutral recently, InfoTrie Sentiment reports. The research firm identifies negative and positive media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. SenesTech earned a daily sentiment score of 0.5 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the near term. View News Stories for SenesTech.

Who are some of SenesTech's key competitors?

Some companies that are related to SenesTech include Wynnstay Group (WYN), Arcadia Biosciences (RKDA), Evogene (EVGN), China Green Agriculture (CGA), Eden Research (EDEN), Bion Environmental Technologies (BNET), Kiwa Bio-Tech Products Group (KWBT) and Cavitation Technologies (CVAT).

What other stocks do shareholders of SenesTech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SenesTech investors own include TransEnterix (TRXC), Carrizo Oil & Gas (CRZO), Marathon Oil (MRO), McDermott International (MDR), Auris Medical (EARS), Melinta Therapeutics (MLNT), ZIOPHARM Oncology (ZIOP), Adamis Pharmaceuticals (ADMP), Catabasis Pharmaceuticals (CATB) and Citius Pharmaceuticals (CTXR).

Who are SenesTech's key executives?

SenesTech's management team includes the folowing people:

Dr. Loretta Powers Mayer, Co-Founder, Chair of the Board, CEO & Chief Scientific Officer (Age 70)
Dr. Cheryl Ann Dyer, Co-Founder, Pres & Chief Research Officer (Age 67)
Mr. Thomas C. Chesterman, Exec. VP, CFO, Treasurer & Assistant Sec. (Age 60)
Ms. Kim Wolin, Exec. VP of Operations & Sec. (Age 64)
Mr. Joe Malinowski, VP of Sales

When did SenesTech IPO?

(SNES) raised $15 million in an IPO on Thursday, December 8th 2016. The company issued 1,900,000 shares at a price of $8.00 per share. Roth Capital Partners acted as the underwriter for the IPO and Craig-Hallum Capital Group was co-manager.

How do I buy shares of SenesTech?

Shares of SNES can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is SenesTech's stock price today?

One share of SNES stock can currently be purchased for approximately $0.56.

How big of a company is SenesTech?

SenesTech has a market capitalization of $15.84 million and generates $300,000.00 in revenue each year. The company earns $-11,910,000.00 in net income (profit) each year or ($0.63) on an earnings per share basis. SenesTech employs 40 workers across the globe.View Additional Information About SenesTech.

What is SenesTech's official website?

The official website for SenesTech is http://www.senestech.com/.

How can I contact SenesTech?

SenesTech's mailing address is 3140 NORTH CADEN COURT SUITE 1, FLAGSTAFF AZ, 86004. The company can be reached via phone at 928-779-4143 or via email at [email protected]

MarketBeat Community Rating for SenesTech (NASDAQ SNES)

Community Ranking:		2.4 out of 5 ( )
Outperform Votes:		293 (Vote Outperform)
Underperform Votes:		308 (Vote Underperform)
Total Votes:		601

MarketBeat's community ratings are surveys of what our community members think about SenesTech and other stocks. Vote "Outperform" if you believe SNES will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SNES will underperform the S&P 500 over the long term. You may vote once every thirty days.

This page was last updated on 1/21/2020 by MarketBeat.com Staff

Your Ultimate Investing Toolkit

Just $1.00 for your first month.